Global Tacrolimus Market Insights, Forecast


 MDPHQEFPD0SF |  Pharma, Healthcare, Life Sciences & Medical |  Jan 25, 2019  |  105



This report studies the global market size of Tacrolimus in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tacrolimus in these regions.
This research report categorizes the global Tacrolimus market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Tacrolimus market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Tacrolimus market based on company, product type, application and key regions.

The various contributors involved in the value chain of Tacrolimus include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Tacrolimus include
GSK
Abbott
Roche Pharma
Novartis
Mylan
Squibb
Astellas
Aarti Group
Takeda
Huapont Pharma
Senju Pharmaceutical
Guike Pharmaceutical
Tecoland
Sandoz
ScinoPharm
RPG Life Science
Suzhou Pharmaceutical Technology
Accura Pharmaceuticals
Fujisawa Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Sinopharm Chuankang Pharmaceutical
Yamanouchi Pharmaceutical
Zhongmei Huadong Pharmaceutical
Hisun Pharmaceutical

Market Size Split by Type
Tacrolimus Capsules
Tacrolimus Ointment
Tacrolimus Injection
Market Size Split by Application
Hospitals
Clinics
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Tacrolimus market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Tacrolimus market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tacrolimus manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tacrolimus with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Tacrolimus submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Tacrolimus are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tacrolimus market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
    1.1  Tacrolimus Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Tacrolimus Market Size Growth Rate by Type
        1.4.2 Tacrolimus Capsules
        1.4.3 Tacrolimus Ointment
        1.4.4 Tacrolimus Injection
    1.5 Market by Application
        1.5.1 Global Tacrolimus Market Size Growth Rate by Application
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Tacrolimus Market Size
        2.1.1 Global Tacrolimus Revenue 2016-2025
        2.1.2 Global Tacrolimus Sales 2016-2025
    2.2 Tacrolimus Growth Rate by Regions
        2.2.1 Global Tacrolimus Sales by Regions
        2.2.2 Global Tacrolimus Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Tacrolimus Sales by Manufacturers
        3.1.1 Tacrolimus Sales by Manufacturers
        3.1.2 Tacrolimus Sales Market Share by Manufacturers
        3.1.3 Global Tacrolimus Market Concentration Ratio (CR5 and HHI)
    3.2 Tacrolimus Revenue by Manufacturers
        3.2.1 Tacrolimus Revenue by Manufacturers (2016-2018)
        3.2.2 Tacrolimus Revenue Share by Manufacturers (2016-2018)
    3.3 Tacrolimus Price by Manufacturers
    3.4 Tacrolimus Manufacturing Base Distribution, Product Types
        3.4.1 Tacrolimus Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Tacrolimus Product Category
        3.4.3 Date of International Manufacturers Enter into Tacrolimus  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Tacrolimus Sales by Type
    4.2 Global Tacrolimus Revenue by Type
    4.3 Tacrolimus Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Tacrolimus Breakdown Data by Application

6 North America
    6.1 North America Tacrolimus by Countries
        6.1.1 North America Tacrolimus Sales by Countries
        6.1.2 North America Tacrolimus Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Tacrolimus by Type
    6.3 North America Tacrolimus by Application
    6.4 North America Tacrolimus by Company

7 Europe
    7.1 Europe Tacrolimus by Countries
        7.1.1 Europe Tacrolimus Sales by Countries
        7.1.2 Europe Tacrolimus Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Tacrolimus by Type
    7.3 Europe Tacrolimus by Application
    7.4 Europe Tacrolimus by Company

8 Asia Pacific
    8.1 Asia Pacific Tacrolimus by Countries
        8.1.1 Asia Pacific Tacrolimus Sales by Countries
        8.1.2 Asia Pacific Tacrolimus Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Tacrolimus by Type
    8.3 Asia Pacific Tacrolimus by Application
    8.4 Asia Pacific Tacrolimus by Company

9 Central & South America
    9.1 Central & South America Tacrolimus by Countries
        9.1.1 Central & South America Tacrolimus Sales by Countries
        9.1.2 Central & South America Tacrolimus Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Tacrolimus by Type
    9.3 Central & South America Tacrolimus by Application
    9.4 Central & South America Tacrolimus by Company

10 Middle East and Africa
    10.1 Middle East and Africa Tacrolimus by Countries
        10.1.1 Middle East and Africa Tacrolimus Sales by Countries
        10.1.2 Middle East and Africa Tacrolimus Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Tacrolimus by Type
    10.3 Middle East and Africa Tacrolimus by Application
    10.4 Middle East and Africa Tacrolimus by Company

11 Company Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.1.4 Tacrolimus Product Description
        11.1.5 Recent Development
    11.2 Abbott
        11.2.1 Abbott Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.2.4 Tacrolimus Product Description
        11.2.5 Recent Development
    11.3 Roche Pharma
        11.3.1 Roche Pharma Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.3.4 Tacrolimus Product Description
        11.3.5 Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.4.4 Tacrolimus Product Description
        11.4.5 Recent Development
    11.5 Mylan
        11.5.1 Mylan Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.5.4 Tacrolimus Product Description
        11.5.5 Recent Development
    11.6 Squibb
        11.6.1 Squibb Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.6.4 Tacrolimus Product Description
        11.6.5 Recent Development
    11.7 Astellas
        11.7.1 Astellas Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.7.4 Tacrolimus Product Description
        11.7.5 Recent Development
    11.8 Aarti Group
        11.8.1 Aarti Group Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.8.4 Tacrolimus Product Description
        11.8.5 Recent Development
    11.9 Takeda
        11.9.1 Takeda Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.9.4 Tacrolimus Product Description
        11.9.5 Recent Development
    11.10 Huapont Pharma
        11.10.1 Huapont Pharma Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Tacrolimus
        11.10.4 Tacrolimus Product Description
        11.10.5 Recent Development
    11.11 Senju Pharmaceutical
    11.12 Guike Pharmaceutical
    11.13 Tecoland
    11.14 Sandoz
    11.15 ScinoPharm
    11.16 RPG Life Science
    11.17 Suzhou Pharmaceutical Technology
    11.18 Accura Pharmaceuticals
    11.19 Fujisawa Pharmaceutical
    11.20 Sichuan Med-Shine Pharmaceutical
    11.21 Sinopharm Chuankang Pharmaceutical
    11.22 Yamanouchi Pharmaceutical
    11.23 Zhongmei Huadong Pharmaceutical
    11.24 Hisun Pharmaceutical

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Tacrolimus Raw Material
        13.1.2 Tacrolimus Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer

Write Us - Contact us


Jot us a note and we’ll get back to you as quickly as possible

Only corporate email-id will be given priority. Please do not provide Gmail,Yahoo,Hotmail,Outlook,Icloud,MSN,Rediff,Naver,QQ,163,123,Yandex, Protonmail,Yopmail,Hanmail,@me.com,@live.com,@mail.com,@gmx.com






Geographical Scope of the Report
Global
Region
Country
   




Purchase options

Single User $ 3900.00
Enterprise User $ 7800.00